Short-term effects of intravitreal ranibizumab and bevacizumab administration on 24-h ambulatory blood pressure monitoring recordings in normotensive patients with age-related macular degeneration
Short-term effects of intravitreal ranibizumab and bevacizumab administration on 24-h ambulatory blood pressure monitoring recordings in normotensive patients with age-related macular degenerationEye advance online publication, January 6 2017.doi:10.1038/eye.2016.305Authors: A Sengul, R Rasier, C Ciftci, O Artunay, A Kockar, H Bahcecioglu& E Yuzbasioglu
Source: Eye - Category: Opthalmology Authors: A Sengul Source Type: research
More News: Age-Related Macular Degeneration (AMD) | Avastin | Lucentis | Opthalmology | Ranibizumab Injection